Cerevel Therapeutics Holdings Inc

Cerevel Therapeutics Holdings Inc

CERE

Market Cap$8.19B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cerevel Therapeutics Holdings IncCerevel Therapeutics Holdings Inc-17.7--82%-0.6
$3.15

Current Fair Value

93% downside

Overvalued by 93% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.19 Billion
Enterprise Value$8.24 Billion
Dividend Yield$0 (0%)
Earnings per Share$-2.67
Beta1.41
Outstanding Shares181,610,675

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-17.73
PEG-66.94
Price to Sales-
Price to Book Ratio14.99
Enterprise Value to Revenue998.77
Enterprise Value to EBIT-17.27
Enterprise Value to Net Income-18
Total Debt to Enterprise0.04
Debt to Equity0.65

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Cerevel Therapeutics Holdings Inc

122 employees

Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focu...